CONTEXT: Obesity is the major determinant of type 2 diabetes (T2D), presumably through its effect on insulin resistance. Genomewide association studies reported many single-nucleotide polymorphisms (SNPs) that increase obesity risk and body mass index (BMI), but their impact on T2D-related traits and risk is unclear. OBJECTIVE: We aimed at analyzing the effect of 24 obesity risk alleles, separately and in combination, on variation of both insulin resistance and b-cell dysfunction, and on T2D risk. DESIGN: We genotyped 24 obesity-associated SNPs and calculated an obesity genotype score (sum of the obesity risk alleles per individual). We analyzed the contribution of each SNP and this score to the variation of four metabolic indices: homeostasis model assessment of insulin resistance (HOMA-IR), homeostasis model assessment of the pancreatic b-cell function (HOMA-B), insulin sensitivity index (ISI) and insulinogenic index (II) (in up to 8050 nondiabetic French individuals) and to T2D risk (in 2077 T2D cases and 3085 controls). RESULTS: We found a highly significant effect of the obesity genotype score on increased insulin resistance adjusted for age and gender (b ¼ 0.02; P-value ¼ 7.16 Â 10 À 9 for HOMA-IR). Individually, we identified nominal or significant association between increased insulin resistance and risk alleles in FAIM2, FTO, GNPDA2, MC4R, NPC1, PTER and SH2B1. Most signals, including the obesity genotype score and FTO SNP, were also associated with increased b-cell function (b ¼ 0.01; P-value ¼ 1.05 Â 10 À 6 and b ¼ 0.04; P-value ¼ 3.45 Â 10 À 4 , respectively). In our T2D case-control study, only the obesity genotype score and the well-known FTO locus significantly contributed to T2D risk (OR ¼ 1.03; P-value ¼ 9.99 Â 10 À 3 and OR ¼ 1.15; P-value ¼ 9.46 Â 10
INTRODUCTION
Obesity and associated co-morbidities such as type 2 diabetes (T2D) have achieved global epidemic proportions, but their origins are still unclear. Although the 'Western way of life', including sedentary life style and high-fat diet among other factors, can explain the increase in prevalence of obesity on a population level, several twin studies have demonstrated that individual variation of body mass index (BMI) persists in the same environment, with heritability estimates ranging between 40 and 70%. 1, 2 So far, genome-wide association studies and their multi-cohorts meta-analyses have reported many single-nucleotide polymorphisms (SNPs) contributing to the variance of BMI and to increased obesity risk. [3] [4] [5] [6] [7] [8] [9] [10] However, few studies have analyzed the contribution of a limited number of these SNPs to T2D risk (or to the variance of related metabolic quantitative traits). [11] [12] [13] [14] In this regard, FTO, 3,15 IRS1, 16, 17 ENPP1, [18] [19] [20] 22 and GIPR 23, 24 have been shown to contribute to the genetic risks of both disorders.
In the present study, we first aimed at analyzing the impact of 24 obesity-associated SNPs (alone or in combination) on metabolic indices of insulin resistance (that is, homeostasis model assessment of insulin resistance (HOMA-IR), insulin sensitivity index (ISI)) and b-cell function (that is, homeostasis model assessment of the pancreatic b-cell function (HOMA-B), insulinogenic index (II)), in a total of 8050 French subjects of European origin for HOMA indices and in 3533 French subjects for both II and ISI. Furthermore, we assessed their association with T2D risk in a French T2D case-control study (N cases ¼ 2077 and N controls ¼ 3085).
MATERIALS AND METHODS

Study population
Clinical characteristics of the studied populations are reported in Table 1 .
The study protocol was approved by the local ethics committee, and participants from all studies (and parents of children) signed an informed consent form.
In the present study, we have analyzed several French (European) populations:
The Data from the Epidemiological Study on the Insulin Resistance Syndrome (D.E.S.I.R.), which is a French general population-based cohort with a longitudinal follow-up of 9 years, fully described elsewhere. 25 Here, we have analyzed 4517 nondiabetic and 111 T2D individuals of this cohort. Lille cohorts including adults and children with a family history of obesity who were recruited by the 'Center National de la Recherche Scientifique' (CNRS-8090, Lille, France) during a media campaign. 26 We have analyzed 3294 adults (2829 nondiabetic and 465 T2D individuals) and 704 unrelated and nondiabetic children. A total of 1501 type 2 diabetic patients from the Corbeil-Essonnes Hospital (Endocrinology-Diabetology department).
Our association study with metabolic traits was based on 8050 nondiabetic participants with fasting plasma glucose (FPG)o7 mmol l À 1 (4517 nondiabetic individuals from D.E.S.I.R., and 2819 nondiabetic adults and 704 children of the Lille cohort).
Our T2D case-control study was based on 2077 type 2 diabetic patients (from D.E.S.I.R., adults of the Lille cohort and Corbeil-Essonnes Hospital) and 3085 normal glucose controls X45 years old (from D.E.S.I.R., and adults of the Lille cohort) (FPGo7 mmol l À 1 ). In the present study, glycemic status was defined according to the 1997 American Diabetes Association recommendations: 27 normal glucose was defined as FPGo6.1 mmol l À 1 without hypoglycemic medication, and a type 2 diabetic subject was defined as FPGX7 mmol l À 1 and/or with antidiabetic treatment.
Genotyping
We have analyzed 24 SNPs based on their observed genome-wide significant effect on obesity traits that were reported in previous genomewide association studies publications:
3-10 rs2844479 (AIF1), rs6265 and rs925946 (BDNF), rs6013029 (CTNNBL1), rs7647305 (ETV5), rs7138803 (FAIM2), rs1421085 and rs6499640 (FTO), rs10938397 (GNPDA2), rs11084753 (KCTD15), rs1424233 (MAF), rs17782313 (MC4R), rs10838738 (MTCH2), rs2815752 (NEGR1), rs1805081 (NPC1), rs6232 and rs6234 (PCSK1), rs4712652 (PRL), rs10508503 (PTER), rs12145833 (SDCCAG8), rs10913469 (SEC16B), rs7498665 (SH2B1), rs6548238 (TMEM18) and rs17150703 (TNKS).
Of note, SNPs located in the same gene (BDNF, FTO or PCSK1) are not in linkage disequilibrium (r 2 o0.2) (Hapmap data in the CEU population and in previous publications 5, 8 ). All the SNPs have been genotyped by SNPlex or TaqMan assays (Applied Biosystems, Carlsbad, CA, USA), according to the manufacturer's instructions. Each SNP showed a genotype success rate of at least 95% (mean call rate of the four studied populations ¼ 99.1% (96.3 À 100.0)) and was in Hardy Weinberg Equilibrium (HWE) in every population (HWE P-value threshold fixed at 0.01).
Statistical analysis
Effects of SNPs on quantitative traits were analyzed by a linear regression model, under an additive model, using R 2.13 software (R Foundation for Statistical Computing, Vienna, Austria). We performed an adjustment for both sex and age, or for sex, age and BMI. Values of HOMA-B, HOMA-IR, II and ISI were logarithmically transformed before statistical analysis as they did not follow a normal distribution.
Meta-analysis for each quantitative trait was performed using a weighted-inverse normal method via the function 'metagen' with a fixed effect in the 'META' R 2.13 package.
The T2D case-control study was performed using a logistic regression adjusted for both sex and age, or for sex, age and BMI (R 2.13 software).
The genotype score is the sum of the obesity risk alleles in each individual. Of note, the genotype score calculation was performed on subjects who have at least 23 successful genotypes (out of 24). A genotype score without FTO SNPs was also assessed, which showed results in the same magnitude of effects and P-values for both HOMA indices and casecontrol study (data not shown).
The unsuccessful genotypes were imputed using the 'mean imputation' method. These imputations were realized only for the genotype score calculation. We obtained a mean imputation rate per SNP of 0.27% (0.00 À 1.42) and a mean imputation rate per genotype score analyses (HOMA-IR, HOMA-B, ISI, II and case-control study) of 6.45% (5.31 À 8.58).
By applying Bonferroni correction, a significant P-value has been considered when below 0.001 (0.05/((24 SNPs þ 1 genotype score)*2)) and a P-value between 0.05 and 0.001 has been considered as a trend of association (or a nominal association).
We assessed the power of our T2D case-control study using QUANTO software (version 1.2.4, University of Southern California, Los Angeles, CA, USA). In our sample (N ¼ 2 077 cases), we had a statistical power higher than 80% to detect an OR of 1.15 for risk allele frequencies ranging between 0.20 and 0.80 ( Figure 1 ).
Phenotyping
To estimate the pancreatic b-cell function and insulin resistance of the peripheral organs, we used HOMA-B and HOMA-IR, respectively. 28 Furthermore, we used two additional indices, II 29 and ISI, 30 in the Lille cohorts as glucose values after an oral glucose tolerance test (OGTT) were available at five time points (0, 30, 60, 90 and 120 min after 75 g of glucose load).
All formulas are described below: Figure 2a) . Furthermore, the obesity risk allele of SNP rs1421085 located in FTO was significantly associated with increased HOMA-IR (b ¼ 0.06; Pvalue ¼ 4.1 Â 10 À 6 ) ( Table 2 and Figure 2a) . We also found nominal associations between increased HOMA-IR and risk allele of the following SNPs: rs7138803 close to FAIM2 (b ¼ 0.03;
À 2 ) and rs7498665 located in SH2B1 (b ¼ 0.03; P-value ¼ 9.4 Â 10 À 3 ) ( Table 2 and Figure 2a ). However, after adjusting for sex, age and BMI, all these associations were abolished, although we identified two novel nominal effects of both rs10838738 located in MTCH2 and rs17150703 near TNKS, on
, respectively) ( Table 2 and Figure 2a ). Regarding HOMA-B, after adjustment for sex and age, the obesity genotype score showed a very significant contribution
) ( Table 2 and Figure 2a) . We also identified a significant association between the obesity risk allele of rs1421085 located in FTO and increased HOMA-B (b ¼ 0.04; Figure 1 . Case numbers needed to achieve 80% of statistical power according to allele frequency and OR. Implication of obesity SNPs on T2D S Robiou-du-Pont et al P-value ¼ 3.5 Â 10 À 4 ) ( Table 2 and Figure 2a) . By using the same adjustment, we found several nominal associations between increased HOMA-B and risk allele of the following SNPs: rs7138803 near the FAIM2 gene (b ¼ 0.02; P-value ¼ 4.
) and rs10913469 located in SEC16B (b ¼ 0.03; P-value ¼ 3.3 Â 10 À 2 ) ( Table 2 and Figure 2a ). However, after adjustment for sex, age and BMI, all these associations disappeared, except for rs10508503 located close to PTER (b ¼ 0.04; P-value ¼ 3.5 Â 10 Effect of obesity-associated SNPs on ISI and II Subsequently, we analyzed the effect of the 24 obesity-associated SNPs on both II and ISI variations in 3533 nondiabetic subjects ( Table 2, Figure 2b and Supplementary Tables 3 and 4) .
By adjusting for sex and age, we identified a nominal contribution of the obesity genotype score to decreased ISI (b ¼ À 0.01; P-value ¼ 1.4 Â 10 À 2 ) ( Table 2 and Figure 2b) . Furthermore, we found nominal associations between ISI variation and obesity risk alleles of the following SNPs: rs1421085 located in FTO (b ¼ À 0.06; P-value ¼ 7.5 Â 10
) and rs10508503 close to PTER (b ¼ À 0.09; P-value ¼ 2.0 Â 10 À 2 ) ( Table 2 and Figure 2b ). After adjustment for sex, age and BMI, the associations between ISI and both rs10838738 located in MTCH2 and rs10508503 close to PTER were still nominally significant (b ¼ 0.05; P-value ¼ 1.9 Â 10 À 2 and b ¼ À 0.07; P-value ¼ 4.5 Â 10 À 2 , respectively) ( Table 2 and Figure 2b ). With the same adjustment, we found a novel trend of association between the risk allele of rs11084753 close to KCTD15 and increased ISI (b ¼ 0.04; P-value ¼ 4.3 Â 10 À 2 ) ( Table 2 and Figure 2b ). Regarding II, by adjusting for sex and age, or for sex, age and BMI, we identified a nominal contribution of rs10938397 close to GNPDA2 (b ¼ À 0.05; P-value ¼ 3.0 Â 10 À 2 or b ¼ À 0.07; P-value ¼ 5.0 Â 10 À 3 , respectively) ( Table 2 and Figure 2b ).
Effect of obesity-associated SNPs on T2D risk Finally, we assessed the effect of the 24 obesity-associated SNPs on T2D risk using a case-control study including 2077 T2D cases and 3085 controls (older than 45 years) ( Table 3) . By using a logistic regression adjusted for age and sex, or for age, sex and BMI, we found a nominal effect of the obesity risk allele of rs2844479 close to AIF1 on decreased T2D risk (OR ¼ 0.90; P-value ¼ 9.6 Â 10 À 3 or OR ¼ 0.89; P-value ¼ 1.3 Â 10 À 2 , respectively). We did not highlight any other nominal or significant association after adjustment for sex, age and BMI. In contrast, by adjusting for sex and age only, we identified a significant association between increased T2D risk and the obesity risk allele of rs1421085 in FTO (OR ¼ 1.15; P-value ¼ 9.5 Â 10 À 4 ) ( Table 3 ). The obesity genotype score also has an effect on increased T2D risk (OR ¼ 1.03; P-value ¼ 1.0 Â 10 À 2 ) (Table 3) . Furthermore, we identified two other nominal associations with T2D risk rs6265 located in BDNF (OR ¼ 1.12; P-value ¼ 2.8 Â 10
) and rs7498665 in the SH2B1 gene (OR ¼ 1.10; P-value ¼ 3.5 Â 10 À 2 ) ( Table 3) .
DISCUSSION
We have analyzed the contribution of 24 obesity SNPs (alone or in combination in a genotype score) to four T2D-related well-known metabolic indices (HOMA-B, HOMA-IR, II and ISI) as well as to T2D risk, based on the observation that most obese subjects develop insulin resistance that occurs before the possible development of chronic hyperglycemia. 31 We identified nominal or significant associations between increased insulin resistance (that is characterized by increased HOMA-IR and/or decreased ISI) and known obesity risk alleles in or near the following genes: FAIM2 (rs7138803), FTO (rs1421085 and rs6499640), GNPDA2 (rs10938397), MC4R (rs17782313), NPC1 (rs1805081), PTER (rs10508503) and SH2B1 (rs7498665), after adjusting the analysis for sex and age only (Figures 2a and b) . These results are reinforced by those found in ISI analyses except for SH2B1 SNP (rs7498665). Indeed, this trait evaluates insulin resistance using OGTT data (namely after an important carbohydrate stress during 2 h), 30 thus providing a more accurate estimate of whole-body insulin resistance than HOMA-IR. 32 Sandholt et al. 13 also showed nominal associations between fasting serum insulin or HOMA-IR and both rs7138803 (FAIM2) and rs10938397 (GNPDA2) in the European Inter99 study, while they did not find any contributions of rs1805081 (NPC1), rs10508503 (PTER) or rs7498665 (SH2B1) (of note, these authors did not analyze FTO or MC4R SNPs). 13 On the other hand, the international MAGIC (meta-analyses of glucose and insulin-related traits consortium) reported nominal associations between HOMA-IR and both FTO SNPs, MC4R rs17782313, NPC1 rs1805081 and SH2B1 rs7498665 in 46 186 nondiabetic participants. 33 However, our signal close to PTER (rs10508503) was not associated with HOMA-IR either in the MAGIC meta-analysis or in the Danish study, and therefore it may be a false-positive association. 13, 33 Our negative Underlining represents association signals with T2D risk, in our case-control study. All associations are adjusted for age and sex, except *, which represents associations adjusted for age, sex and BMI. ** represents significant associations adjusted for age and sex or for age, sex and BMI.
results were also negative in MAGIC, except for AIF1 rs2844479 and TMEM18 rs6548238, which showed nominal associations with both HOMA-IR and HOMA-B. 33 The role of these obesityassociated SNPs in glucose metabolism is further supported by the very significant association between the obesity genotype score, which is the sum of all obesity risk alleles per individual, and increased HOMA-IR and decreased ISI, when adjusted for sex and age only (Figures 2a and b) . Many of the insulin resistanceassociated signals were also associated with increased b-cell function (that is characterized by increased HOMA-B) (Figure 2a ). This result is not surprising as the pancreatic islets' response to obesity-associated insulin resistance is usually an increase in insulin secretion (known as 'b-cell compensation') that maintains normal plasma glucose levels as long as possible. 34 This b-cell compensation may be due to an expansion of the pancreatic b-cell mass 34, 35 and/or an increase in b-cell function. 34 Importantly, when adjusted for age, sex and BMI almost all association signals with insulin resistance and/or b-cell function were abolished (including the effect of the obesity genotype score). This result shows that the excess of adiposity mediates most of the contributions of the associated SNPs to T2D-related metabolic phenotypes.
The well-confirmed role of FTO SNP in increased T2D risk was confirmed in the French population, and further adjustment for BMI abolished the association with T2D in our sample. These data support the view that FTO predisposes to T2D mainly through its effect on adiposity, in line with previous reports in the European populations. 36, 37 Furthermore, we found that the obesity risk alleles of both rs6265 (BDNF) and rs7498665 (SH2B1) contributed to increased T2D risk, which has been found in Danish, Chinese and Japanese populations. 12, 13, 38 Interestingly, we found that the obesity genotype score, which increased both HOMA-B and HOMA-IR indices, was also associated with a modest BMI-dependent increase in T2D risk (on average 3% of increase in T2D risk by additional obesity risk allele), which implies that the accumulation of obesity risk alleles may predispose to T2D in parallel with the development of insulin resistance and its transient b-cell compensation. These results are in line with a previous report by Li et al. 39 in the EPIC/Norfolk prospective cohort from the UK. Furthermore, it is noteworthy that these results are not mediated by FTO SNPs. Surprisingly, the obesity risk allele of rs2844479 (AIF1) decreased the T2D risk when the analysis was adjusted for age and sex or for age, sex and BMI. This association signal was also nominally found by the international DIAGRAM consortium (diabetes genetics replication and meta-analysis consortium) (OR ¼ 0.95; P-value ¼ 0.016). 40 The MAGIC meta-analysis reported nominal association of the same AIF1 allele with decreased HOMA-B and decreased HOMA-IR, suggesting a beneficial effect on insulin sensitivity that would deserve additional investigations.
The trend of association of MTCH2 for ISI after adjustment for sex, age and BMI has already been reported in a study implicating 926 Swedish men of the ULSAM cohort.
14 In addition to this result, we highlight an association of this locus with HOMA-IR and HOMA-B, but further confirmation is needed at this stage.
Differences in the mean values of HOMA-IR, HOMA-B, ISI and II were observed between children and adults of the Lille cohort but they did not mediate the results of the present study. As a matter of fact, our meta-analysis takes into account the size of each cohort, thus weighting the probable effect of this difference. Moreover, our method did not show a heterogeneity between cohorts (P heterogeneity 40.05), indicating a statistical homogeneity of the analyzed traits in the cohorts.
In conclusion, we found several obesity-associated SNPs that contributed to increased insulin resistance and compensated for Implication of obesity SNPs on T2D S Robiou-du-Pont et al the increased b-cell function in nondiabetic individuals. Only a few were also associated with T2D risk in our study, despite their impact on adiposity, which may imply a possible long-term 'b-cell compensation' that may protect against T2D development. This result suggests that some markers of weight gain do not necessarily contribute to the T2D genetic background, which fits well with the so-called possible 'healthy obesity' phenotype. 41, 42 
